TSX News -
Trican Announces Pricing of Secondary Offering of Keane Shares
CALGARY, Alberta, Dec. 03, 2018 (GLOBE NEWSWIRE) — Trican Well Service Ltd. (TSX: TCW) (“Trican” or the “Company”) today announced the […]
THL Credit Senior Loan Fund Declares Monthly Distribution of $0.101 Per Share and Announces Investor Call
BOSTON, Dec. 03, 2018 (GLOBE NEWSWIRE) — THL Credit Senior Loan Fund (the “Fund”) (NYSE: TSLF) today announced the declaration […]
Friedman Industries, Incorporated Announces Cash Dividend
Longview, Texas, Dec. 03, 2018 (GLOBE NEWSWIRE) — Friedman Industries, Incorporated (NYSE—American; Trading Symbol: FRD) The Board of Directors of […]
Updated Interim Results from Ongoing Phase 2a Study of Portola Pharmaceuticals’ Oral Syk/JAK Inhibitor Cerdulatinib Continues to Demonstrate Clinical Responses in Heavily Pre-Treated T-Cell Malignancies
– Early Signs of Durable Response Across Patients with Relapsed/Refractory PTCL – – 50 Percent Complete Response Rate Observed in […]
Mitel Partners with Tradewinds Brokerage to Accelerate UCaaS Business in Australia, New Zealand
Expands relationship with Tradewinds to address the growing global demand for cloud collaboration and communications services Enhances regional alignment with […]
Kayne Anderson Midstream/Energy Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at November 30, 2018
HOUSTON, Dec. 03, 2018 (GLOBE NEWSWIRE) — Kayne Anderson Midstream/Energy Fund, Inc. (the “Fund”) (NYSE: KMF) today provided a summary […]
Kayne Anderson MLP/Midstream Investment Company Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at November 30, 2018
HOUSTON, Dec. 03, 2018 (GLOBE NEWSWIRE) — Kayne Anderson MLP/Midstream Investment Company (the “Company”) (NYSE: KYN) today provided a summary […]
Atara Biotherapeutics Announces Next-Generation CAR T Discoveries and Positive T-Cell Immunotherapy Results in Patients with EBV+ PTLD Involving the CNS at 60th American Society of Hematology (ASH) Annual Meeting
Moffitt Cancer Center collaborators described next-generation chimeric antigen receptor T-cell (CAR T) technology that increases T cell persistence and decreases […]
Allogene Therapeutics and Servier Present Pooled Data from Phase 1 Trials of Allogeneic UCART19 in Relapsed/Refractory Acute Lymphoblastic Leukemia
82 percent of Patients Achieved a Complete Remission when Lymphodepletion Regimen Included an anti-CD52 Monoclonal Antibody (mAb) Safety Profile of […]
ValOre Announces Rights Offering
VANCOUVER, British Columbia, Dec. 03, 2018 (GLOBE NEWSWIRE) — ValOre Metals Corp. (TSX-V: VO) (“ValOre” or the “Company”) today announced […]
